A modern thrombolysis service is superior to primary angioplasty

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy for STE-MI
Advertisements

Local improvement following national clinical audit workshops Auditing heart attacks Saving lives Dr Andrew Wragg Barts Health.
BASE HOSPITAL GROUP ONTARIO Chapter 3 for 12 Lead Training -WHY 12 LEAD- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE.
Chapter 3 for 12 Lead Training -Precourse-
Presented by: Fahim H. Jafary, M.D., F.A.C.C. Associate Professor of Medicine Aga Khan University Hospital, Karachi March 14, 2008 Primary Percutaneous.
Regional AMI Care: Bridging the Rural Health Care Gap Darren B. Bean, MD University of Wisconsin Emergency Medicine/Medflight Director UW Level 1 Heart.
Optimal Timing of PCI in ACS Patrick Hildbrand. Trends and Prognosis in ACS Furman MI, JACC 2001, 37: Hospital 1 year.
Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI: The Mayo Clinic Protocol Henry H. Ting, MD, MBA Associate Professor of.
Utilization of Rescue and Facilitated Angioplasty for Primary PCI: Who Should Get Lytic Therapy in 2009? Adnan Kastrati Deutsches Herzzentrum, Technische.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
PPCI – National Update NCBC Workshop Jim McLenachan, National Clinical Lead for PPCI, NHS Improvement, England. London, 24 th November, NCBC Annual.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
Clinical Trial Results. org Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis.
Primary PCI Treatment of choice for Acute MI.
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
ACS and Thrombosis in the Emergency Setting
MD DM DNB FACC FICC FCSI FESC LAKSHMI HOSPITAL, PALAKKAD.
Advanced Cardiovascular Intervention 2009 Timings in PPCI: Have we learnt the lessons from our European Colleagues? Peter F Ludman.
Ambulance Victoria and MonashHEART Acute Myocardial Infarction (Mon-AMI) 12 lead ECG project. An update On behalf of the MonAMI Team A Hutchison, Y Malaiapan,
A H Gershlick University Hospital of Leicester UK A H Gershlick University Hospital of Leicester UK AA 2008 Who should we rescue ?
Prehospital Fibrinolysis with Double Antiplatelet Therapy in Acute ST-Elevation Myocardial Infarction: The Clarity Ambulance Substudy Prehospital Fibrinolysis.
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
Primary Angioplasty – The case is not proven: pre-hospital thrombolysis with mandated PCI may be equally effective Primary Angioplasty – The case is not.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
To Transfer or Not to Transfer? The debate between transfer for PCI versus local thrombolysis. Todd Ring, BSc., MD, CCFP March 11, 2004 University of Calgary.
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
Advanced Angioplasty 2005 Primary PCI making it happen Data collection and Timings Peter Ludman University Hospital Birmingham.
Heart Attack Centres: Every Network Should Have (at least) One Dr Rod Stables The Liverpool Heart and Chest Hospital.
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
Pre-hospital Thrombolysis in the UK - looking ahead Richard Vincent Royal Sussex County Hospital, Brighton.
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
West Hertfordshire Primary Angioplasty Service Masood Khan.
Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.
PCI for STEMI Ari de la Hera, M.D..
1 Advanced Angioplasty London, England 27 January, 2006 Jörg Michael Rustige,MD Medical Director Lilly Critical Care Europe, Geneva.
Door to Balloon Time: Does it Matter? Tale of Two Studies.
Dr Martyn Thomas Kings College Hospital Primary angioplasty “A UK Experience” “The UK experience”
Agrément FMC N° Conflits d’intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos.
S. Chiu Wong MD, FACC Associate Professor of Medicine Weill Medical College of Cornell University Director, Cardiac Catheterization Laboratories The New.
Blue light to the East of England Heart Attack Centres Dr Sarah Clarke Consultant Cardiologist And Clinical Director Cardiac Services Papworth Hospital.
Transfers, Facilitated and Rescue PCI for AMI Michael J Cowley, M.D., FSCAI Nothing to disclose.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
Challenges in Pre Hospital Diagnosis & Management of Acute MI
CRT 2015 Unmet Needs in STEMI Interventions
The American College of Cardiology Presented by Dr. Adnan Kastrati
Optimising STEMi Care- Role of Nurses and Paramedics
Eva Kline-Rogers RN, NP, AACC University of Michigan
Heart Disease in the Acute Hospital
Singapore’s Experience in Primary PCI in the Last Ten Years
European Heart Association Journal 2007 April
American College of Cardiology Presented by Dr. Michel R. Le May
Circulation 2001;104: Circulation 2001;104:
Maintenance of Long-Term Clinical Benefit with
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Presentation transcript:

A modern thrombolysis service is superior to primary angioplasty Rob Henderson Consultant Cardiologist Trent Cardiac Centre Nottingham

Responses to a request to defend thrombolysis at BCIS Autumn meeting Thanks…..but NO!

Responses to a request to defend thrombolysis at BCIS Autumn meeting Yes……but can I take the other side?

Fibrinolytic Therapy Triallists 35 Day Outcome in 58 600 patients 16 per 1000 lives saved Lancet 1994:343;311

Thrombolysis equivalence trials ‘ceiling’ of benefit? 30 d mortality

Thrombosaurus Rex EXTINCTOPLASE ? Courtesy Bob Wilcox

Patency of infarct-related artery NEJM 1993;335:1313 % Patients PCI

Keeley et al, 2003 OR 0.70, 95% CI 0.59-083, P<0.0001

Short-term clinical outcomes Quantitative review of 23 trials of primary angioplasty versus thrombolysis (n=7739) Short-term clinical outcomes Keeley, Lancet 2003;361:13

Keeley meta-analysis of 23 trials Some limitations… Suboptimal lytic strategies symptom onset to drug ≈ 3 hrs streptokinase in 8 trials Inclusion of SHOCK trial (only 63% lysis) End-points not defined, no blinded validation Most trials (15) had fewer than 200 patients Double counting of fatal stroke 2% excess major bleeding in PPCI group

Keeley meta-analysis: proof of concept? Patient group N Absolute mortality difference OR 95%CI P value All 23 trials 7739 2.3% 0.70 (0.59-0.83) <0.0001 PCI vs fibrin-specific lytic 5902 1.7% 0.77 (0.63-0.94) 0.009 PCI vs acc tPA 5314 1.6% 0.78 (0.64-0.96) 0.019 PCI vs acc tPA, excluding SHOCK 5012 1.2% 0.81 (0.64-1.02) 0.07

OR 0.81, 95% CI 0.64-1.02, P=0.07

NRMI-2: Primary angioplasty versus thrombolysis Real life registry Median presentation to alteplase time 42 min Median presentation to balloon time 111 min Mortality no different because delay to PCI? Presentation to alteplase 42 min Presentation to balloon 111 min Tiefenbrunn, JACC 1998;31:1240

Problem with primary PCI……

Reperfusion therapy Time is muscle is survival

Thrombolysis: the ‘golden hour’ Absolute reduction in 35 day mortality per 1000 patients treated 20 40 60 80 3 6 9 12 15 18 21 24 Lives saved per 1000 treated patients Treatment delay (h) FTT data - closed circles Smaller trials - open circles Boersma, Lancet 1996;348:771

Time delay from symptom onset to primary PCI: every minute counts 60 120 180 240 300 360 2 4 6 8 10 12 6 RCTs of primary PCI by the Zwolle group 1994-2001 (1791 STEMI patients) One year mortality (%) Risk of one year mortality increases by 7.5% for each 30 min delay RR 1.08 for every 30 min delay 95% CI 1.01-1.16, p<0.0001 Ischaemic time (mins) De Luca, Circulation 2004;109:1223

23 trials of PCI versus thrombolysis (n=7419) -5 5 10 15 20 40 60 80 100 PCI-related time delay (mins) in 4-6 week mortality (%) Absolute benefit of PCI Mean delay 39.5 min (SD 22.1) For every 10 min delay there is 0.94% decrease in mortality benefit, p=0.006. No benefit if delay>62mins PCI-time delay is difference between door-to-balloon and door-to-needle times Analysis assumes linear association between time delay and outcome Time delay may be a marker for PCI quality and hence benefit Only 2 studies with time delay >60mins Mean delay 39.5 min (SD 22.1, range 7-104) Circles reflect trial sample size Blue line: weighted meta-regression Nallamothu, Am J Cardiol 2003;92:824

Relationship between time of day and time to reperfusion 67.9% lysis and 54.2% PPCI were treated off hours STEMI with diagnostic ECG within 6hrs of admission Regular hours = weekdays 7am to 5pm 67.9% lysis and 54.2% PPCI were treated off hours NRMI registry 1999-2002 Magid, JAMA 2005;294:803

Main cause of delay to treatment

Delays to treatment in AMI TIME Patient education Pre-hospital intervention (lytics, IIbIIIa etc) Logistics Interhospital transfer

Meta-analysis of 6 trials of pre-hospital thrombolysis (n=6436) % mortality in-hospital thrombolysis % mortality pre-hospital 2 4 6 8 10 12 14 Time from symptoms (SE) to thrombolysis: 104 (7) min for pre-hospital 162 (16) mins for in-hospital (Urokinase, anistreplase, t-PA) For all cause in-hospital mortality OR 0.83 95% CI 0.70-0.98 Morrison, JAMA 2000;283:2686

Comparison of primary PCI and prehospital thrombolysis in acute MI (CAPTIM n=840) Events at 30 days Differences not significant 26% of pre-hospital lysis group underwent PCI P=0.61 P=0.29 Planned 1200 patients Symptoms to lysis 130 min Symptoms to balloon 190 min Bonnefoy, Lancet 2002;360:825

Pre-hospital thrombolysis vs primary PCI French Nationwide USIC 2000 registry (n=1922) Age-adjusted survival (%) 100 Pre-hospital lysis 94% 95 In-hospital lysis 89% 90 Primary PCI 89% % 85 80 No reperfusion 79% P<0.0001 75 180 360 days Danchin et al, Circulation 2004;110:1909

Grampion region early anistreplase trial Delaying thrombolysis by 1 hour results in 43 additional deaths per 1000 lives over 5 years Years 1 2 3 4 5 60 70 80 90 100 % Survival Prehospital lysis 75% In-hospital lysis 64% Rawles, J Am Coll Cardiol 1997;30:1181

Time from symptom onset to treatment in recent trials Time from symptom onset to treatment (mins)

Onset of pain to needle time East Midlands Ambulance Service Median symptom onset to needle 93 minutes N=117 EMAS PHT audit 04/05

Pre-hospital thrombolysis in the UK (27 of 31 ambulance services participating) 2877 patients treated Ambulance Service Association and Joint Royal Colleges Ambulance Liaison committee http://www.asancep.org.uk/thromb%20update%20August05.doc

Dr Curzen liaises with Hampshire Ambulance Service Trust At July 05 HAST had treated 8 patients with pre-hospital lysis

Primary PCI - providing a UK service? In 2004 there were 3447 STEMI interventions This morning Peter Ludman estimated number of STEMIs requiring reperfusion at 30000 Provision of nationwide PPCI service is not feasible in the short term!

What would you want…? You develop central chest pain…. The paramedic arrives and does an ECG…. The ECG is faxed to the local CCU who confirm evolving anterior myocardial infarction

What would you want…? The local DGH is 30 mins away.…and the door to balloon time is 30 mins The local PCI unit is 45 mins away…. and the door to balloon time is 90 mins The paramedic is clutching a syringe of lytic... The choice is yours!

Conclusions For foreseeable future thrombolysis will remain the default reperfusion strategy in most UK hospitals Pre-hospital thrombolysis saves lives and is only practical strategy for timely delivery of reperfusion therapy The NHS should fully implement a national programme of pre-hospital thrombolysis (with rescue PCI as necessary) targeting symptom-onset to drug times less than 120 minutes Primary PCI programmes are costly, potentially delay treatment, and disturb our sleep!

My opponent has a tendency to overestimate size! (and treatment effect)

National Infarct Angioplasty Pilot (NIAP) 3 of 6 pilot sites are not running 24/7 At 1 centre median door to balloon times were >90 mins for 5 consecutive months

Introduction of Primary PCI at a NIAP centre …..careful case selection?

Comparison of angioplasty and prehospital thrombolysis in acute MI (CAPTIM n=840) Mortality at 30 days Time from symptoms to treatment Cardiogenic shock occurred in 1.3% of patients treated <2hrs and 5.3% of patients treated >2hrs N=460 N=374 Interaction test HR 4.19, 95%CI 1.03-17.0, p=0.045 Steg, Circulation 2003;108:2851

Meta-analysis in cardiology Hypothesis-generating or definitive research? Rx for STEMI Meta-analysis Definitive trial iv magnesium +ve ISIS-4 iv nitrate GISSI-3 GIK ? Primary PCI